MedNews Week
S

What Is the “Normal” Sarcoma Immune Microenvironment?

By MedNews Week FEATURING Seth Pollack
By MedNews Week FEATURING Seth Pollack
0 views
August 8, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
13:04
Douglas Beall

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

27:04
Fengting Yan

Cancer Screening Molecular Tools

07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

22:07
Total Health

2024 Update in Sarcomas

Feat. D. Portnoy
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
19:40
Warren Chow

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
33:54
Yale Cancer Center

Osteolytic Skeletal Metastases: AORIF as a New Strategy for Enhanced…

Feat. F. Lee
11:17
Jack William Jennings

NCCN Guidelines on Utilizing Radio-Frequency Ablation to Treat Metas…

10:41
Francesco Massari

Treatment Approaches in Bone Metastases Pain Management

25:23
Andrea Napolitano

NCCN Clinical Practice Guidelines for Treating GIST

21:12
ISCO - International School of Clinical Oncology

What Is New in Treatment of Soft Tissue and Bone Sarcoma

Feat. S. Stacchiotti
25:02
Total Health

Sarcoma 101: Multidisciplinary Approach, Therapies, and Future Direc…

Feat. B. Wilky
15:45
i3 Health

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

Feat. S. Patel, B. Ruben, K. Polson
10:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Feat. R. Jones
16:37
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Highlights in Sarcomas

Feat. R. Jones
22:21
Miami Cancer Institute Precision Oncology Symposium

Divide and Conquer Sarcomas Through Precision Oncology

Feat. N. Somaiah
18:44
2023 West Oncology Conference

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Feat. B. Van Tine
10:48
Insights from 2024 ASCO® GI Annual Meeting

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Feat. J. Zalcberg
09:02
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA…

Feat. Y. Chae